Aspira Women's Health
Financial ratios & Valuation

Forward Multiples (2025 – 2027)

202520262027
Price/Earnings ratio
-0.07-0.11N/A
Price/Sales ratio
0.430.270.12
Earnings per Share (EPS)
$-1.02$-0.73N/A

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-3.73-4.39-3.27-10.46-1.84-4.72-38.33-6.20-0.11-2.25-1.03-1.84
Price/Sales ratio
28.4838.5418.5535.216.8815.45145.3128.890.314.113.8015.45
Price/Book Value ratio
3.724.7813.0332.252.938.0269.536.520.38-15.926.862.93
Price/Cash Flow ratio
-4.27-4.56-3.51-13.51-2.24-5.40-45.87-7.18-0.07-2.37-0.94-2.24
Price/Free Cash Flow ratio
-4.20-4.32-3.22-13.42-2.21-5.35-44.39-7.13-0.07-2.36-0.94-2.21
Price/Earnings Growth ratio
-0.140.190.110.280.15-0.82-16.42-0.09-0.000.02-0.09-0.09
Dividend Yield
N/AN/AN/A0.85%N/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
51.20%-6.06%-2.11%6.63%-2.91%26.33%26.57%44.95%52.77%57.48%51.43%-2.91%
Operating Profit Margin
-762.03%-884.19%-566.01%-334.54%-371.20%-336.66%-386.60%-478.49%-400.35%-205.94%-413.67%-336.66%
Pretax Profit Margin
-761.95%-878.04%-566.54%-336.33%-372.45%-335.76%-384.97%-464.79%-331.98%-182.32%-367.95%-372.45%
Net Profit Margin
-761.95%-878.04%-566.54%-336.33%-372.45%-327.12%-379.05%-465.50%-263.62%-182.32%-367.95%-372.45%
Effective Tax Rate
0.94%1.66%4.64%7.08%0.33%2.57%1.53%-0.15%20.59%N/AN/A2.57%
Return on Assets
-79.46%-91.19%-186.65%-140.01%-99.67%-107.35%-89.92%-77.19%-124.18%-266.52%-257.18%-107.35%
Return On Equity
-99.76%-108.94%-397.87%-308.10%-158.99%-169.89%-181.39%-105.09%-320.53%705.70%-332.35%-169.89%
Return on Capital Employed
-99.77%-109.31%-273.98%-213.60%-134.21%-155.10%-136.16%-98.06%-282.50%-1649.34%-433.10%-155.10%
Liquidity Ratios
Current Ratio
4.815.772.382.413.633.372.90N/AN/AN/A2.823.37
Quick Ratio
4.815.752.342.373.603.362.905.082.760.982.513.36
Cash ratio
4.665.562.042.123.152.942.594.742.300.502.302.94
Days of Sales Outstanding
24.1714.5837.9923.9793.9674.3167.8855.0255.5258.1737.4274.31
Days of Inventory outstanding
N/A13.7512.5812.7710.682.723.2016.9329.8421.2819.5510.68
Operating Cycle
24.1728.3350.5736.75104.6577.0471.0871.9685.3679.4628.7877.04
Days of Payables Outstanding
333.24156.18119.1893.31110.35126.43117.89146.0983.19118.2554.53126.43
Cash Conversion Cycle
-309.06-127.84-68.61-56.56-5.70-49.38-46.80-74.132.16-38.79-12.28-12.28
Debt Ratios
Debt Ratio
0.04N/A0.230.220.120.090.240.090.200.360.610.12
Debt Equity Ratio
0.05N/A0.490.480.200.140.480.120.51-0.951.580.20
Long-term Debt to Capitalization
N/AN/A0.300.300.150.110.260.080.25-1.520.250.15
Total Debt to Capitalization
0.05N/A0.320.320.170.120.320.100.34-22.880.290.17
Interest Coverage Ratio
N/AN/A-534.07-248.59N/AN/AN/AN/AN/AN/A-2.00KN/A
Cash Flow to Debt Ratio
-15.19N/A-7.55-4.87-6.32-10.03-3.11-7.40-9.24-7.01-17.41-10.03
Company Equity Multiplier
1.251.192.132.201.591.582.011.362.58-2.642.581.59
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-6.66-8.43-5.28-2.60-3.06-2.85-3.16-4.02-3.93-1.73-4.00-2.85
Free Cash Flow / Operating Cash Flow Ratio
1.011.051.091.001.011.011.031.001.001.001.001.01
Cash Flow Coverage Ratio
-15.19N/A-7.55-4.87-6.32-10.03-3.11-7.40-9.24-7.01-17.41-10.03
Short Term Coverage Ratio
-15.19N/A-76.71-43.94-49.56-67.18-11.73-27.95-27.57-19.01-101.37-67.18
Dividend Payout Ratio
N/AN/AN/A-8.97%N/AN/AN/AN/AN/AN/AN/AN/A